siRNA, Anti-DAGLA, 2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT01500WQ-2OMe)

The product SIRGT01500WQ-2OMe is a type of small interfering RNA (siRNA) that targets DAGLA gene and regulates the expression of gene. The siRNA interferes with the expression of DAGLA gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_006133.2
Alternative Names C11orf11; DAGL(ALPHA); DAGLALPHA; NSDDR
Related Diseases Spinocerebellar Ataxia, Spasmodic Dysphonia
Purification HPLC
Target Gene
Gene ID 747
Uniprot ID Q9Y4D2
Sub Cat Target Species Modification Scale  
SIRGT03500WQ-2MOE DAGLA Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT04500WQ-LNA DAGLA Human Locked Nucleic Acid (LNA) Inquiry
SIRGT01500WQ-RB DAGLA Human Ribo-modified Inquiry
SIRGT02500WQ-BB DAGLA Human Backbone-modified Inquiry

Related Products